Brecanavir
Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV. On December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.
Wikipage redirect
primaryTopic
Brecanavir
Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV. On December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.
has abstract
Brecanavir (INN; codenamed GW6 ...... issues regarding formulation.
@en
ATC prefix
CAS number
313682-08-5
FDA UNII code
E367I8C7FI
IUPAC name
[(3R,3aS,6aR)-2,3,3a,4,5,6a-He ...... xy]phenyl]butan-2-yl]carbamate
@en
PubChem
thumbnail
Wikipage page ID
17,891,952
Wikipage revision ID
734,230,755
ChEMBL
ChemSpiderID
molecular weight
smiles
O=SNC[C@@H][C@@H]Cc6ccccc6
StdInChIKey
JORVRJNILJXMMG-OLNQLETPSA-N
Verifiedfields
verifiedrevid
459,812,959
Watchedfields
subject
hypernym
comment
Brecanavir (INN; codenamed GW6 ...... issues regarding formulation.
@en
label
Brecanavir
@en
